106 related articles for article (PubMed ID: 17846770)
1. A case of ABL deletion in a patient with precursor B cell lymphoblastic leukemia.
Huh J; Moon H; Chung W
Ann Hematol; 2008 Mar; 87(3):239-41. PubMed ID: 17846770
[No Abstract] [Full Text] [Related]
2. ABL deletion without associated BCR-ABL in precursor B-cell acute lymphoblastic leukemia.
Lo A; Gu G; Liu M; Dev VG
Leuk Res; 2009 Aug; 33(8):e98-103. PubMed ID: 19282030
[No Abstract] [Full Text] [Related]
3. ABL1 deletion without BCR/ABL1 rearrangement is originated from a large-sized 9q deletion.
Huh J; Mun YC; Seong CM; Chung WS
Ann Hematol; 2012 Nov; 91(11):1813-5. PubMed ID: 22453304
[No Abstract] [Full Text] [Related]
4. ABL oncogene amplification with p16(INK4a) gene deletion in precursor T-cell acute lymphoblastic leukemia/lymphoma: report of the first case.
Kim HJ; Woo HY; Koo HH; Tak EY; Kim SH
Am J Hematol; 2004 Aug; 76(4):360-3. PubMed ID: 15282669
[TBL] [Abstract][Full Text] [Related]
5. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.
Medeiros BC
N Engl J Med; 2009 Apr; 360(17):1787; author reply 1787-8. PubMed ID: 19387020
[No Abstract] [Full Text] [Related]
6. Isolated del(14)(q21) in a case of precursor B-cell acute lymphoblastic leukemia.
Meloni-Ehrig AM; Tirado CA; Chen K; Jahn J; Suchan S; Scheerle J; Crosby MG; Meany H; Seibel N; Leitenberg D; Heritage DW; Mowrey PN
Cancer Genet Cytogenet; 2005 Aug; 161(1):82-5. PubMed ID: 16080963
[TBL] [Abstract][Full Text] [Related]
7. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
8. Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia.
Collette Y; Prébet T; Goubard A; Adélaïde J; Castellano R; Carbuccia N; Garnier S; Guille A; Arnoulet C; Charbonier A; Mozziconacci MJ; Birnbaum D; Chaffanet M; Vey N
Blood Cancer J; 2015 Mar; 5(3):e292. PubMed ID: 25768406
[No Abstract] [Full Text] [Related]
9. Philadelphia chromosome positive acute B-lymphoblastic leukemia with extreme leukocytosis.
Bhatnagar V; Emadi A
Blood; 2013 Aug; 122(7):1104. PubMed ID: 24137641
[No Abstract] [Full Text] [Related]
10. Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study.
Kim M; Yim SH; Cho NS; Kang SH; Ko DH; Oh B; Kim TY; Min HJ; She CJ; Kang HJ; Shin HY; Ahn HS; Yoon SS; Kim BK; Shin HR; Han KS; Cho HI; Lee DS
Cancer Genet Cytogenet; 2009 Nov; 195(1):59-65. PubMed ID: 19837270
[TBL] [Abstract][Full Text] [Related]
11. Unusual course of an acute lymphoblastic leukemia case with i(9q) as a sole cytogenetic abnormality.
Cogulu O; Karapinar DY; Karaca E; Aydinok Y; Ozkinay F
Leuk Res; 2006 Nov; 30(11):1461-3. PubMed ID: 16564090
[TBL] [Abstract][Full Text] [Related]
12. Homozygous deletions of CDKN2A are present in all dic(9;20)(p13·2;q11·2)-positive B-cell precursor acute lymphoblastic leukaemias and may be important for leukaemic transformation.
Zachariadis V; Schoumans J; Barbany G; Heyman M; Forestier E; Johansson B; Nordenskjöld M; Nordgren A
Br J Haematol; 2012 Nov; 159(4):488-91. PubMed ID: 22994152
[No Abstract] [Full Text] [Related]
13. Translocation (14;14)(q11;q32) with simultaneous involvement of the IGH and CEBPE genes in B-lineage acute lymphoblastic leukemia.
Han Y; Xue Y; Zhang J; Wu Y; Pan J; Wang Y; Shen J; Dai H; Bai S
Cancer Genet Cytogenet; 2008 Dec; 187(2):125-9. PubMed ID: 19027493
[TBL] [Abstract][Full Text] [Related]
14. Clonal relationship between precursor B-cell acute lymphoblastic leukemia and histiocytic sarcoma: a case report and discussion in the context of similar cases.
McClure R; Khoury J; Feldman A; Ketterling R
Leuk Res; 2010 Feb; 34(2):e71-3. PubMed ID: 19744706
[No Abstract] [Full Text] [Related]
15. Cryptic genomic abnormalities associated with coexpression of KOR-SA3544 and NG.2 in proB acute lymphoblastic leukemia.
Bumbea H; Serghei L; Vlădăreanu AM; Stefan LM; Casleanu D; Voican I; Begu M
Rom J Intern Med; 2007; 45(4):387-91. PubMed ID: 18767415
[TBL] [Abstract][Full Text] [Related]
16. Novel IGHalpha translocations, t(2;14)(q14.3;q32) and t(14;17)(q32;q21), in B-cell precursor acute lymphoblastic leukemia.
Aventín A; Sánchez J; Nomdedéu JF; Estany C; Forcada P; La Starza R; Mecucci C
Cancer Genet Cytogenet; 2008 Aug; 185(1):57-9. PubMed ID: 18656697
[No Abstract] [Full Text] [Related]
17. Primary precursor B-cell lymphoblastic lymphoma of the ovary: case report and review of the literature.
Sakurai N; Tateoka K; Taguchi J; Terada T
Int J Gynecol Pathol; 2008 Jul; 27(3):412-7. PubMed ID: 18580320
[TBL] [Abstract][Full Text] [Related]
18. Dicentric (9;12) in pre-B acute lymphoblastic leukemia (ALL) in an infant.
Stark B; Jeison M; Luria D; Cohen IJ; Goshen Y; Fisher S; Zaizov R
Leukemia; 1996 Jan; 10(1):183-4. PubMed ID: 8558927
[No Abstract] [Full Text] [Related]
19. Systemic mastocytosis with associated myeloproliferative disease and precursor B lymphoblastic leukaemia with t(13;13)(q12;q22) involving FLT3.
Tzankov A; Sotlar K; Muhlematter D; Theocharides A; Went P; Jotterand M; Horny HP; Dirnhofer S
J Clin Pathol; 2008 Aug; 61(8):958-61. PubMed ID: 18663058
[TBL] [Abstract][Full Text] [Related]
20. dic(7;9) with loss of Tp53 gene in acute lymphoblastic leukemia.
Gupta A; Reddy KG; Goyal M; Karwa P; Swarupa DG; Kasaragadda MR
Indian J Pathol Microbiol; 2016; 59(4):571-573. PubMed ID: 27721307
[No Abstract] [Full Text] [Related]
[Next] [New Search]
